Armata Pharmaceuticals In... (ARMP)
AMEX: ARMP
· Real-Time Price · USD
2.55
0.02 (0.79%)
At close: Aug 15, 2025, 3:56 PM
2.34
-8.24%
After-hours: Aug 15, 2025, 06:13 PM EDT
Armata Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 6.87M | 4.7M | 5.17M | 5.47M | 3.72M | 4.7M | 4.53M | 4.05M | 4.17M | 5.07M | 5.51M | 4.46M | 3.12M | 1.24M | 1.07M | 1.03M | 1.03M | 1.07M |
Cost of Revenue | 1.44M | 1.39M | 1.32M | 1.24M | 33.97M | 33.86M | 33.77M | 33.72M | 901K | 896K | 8.69M | 13.26M | 18.66M | 23.69M | 20.02M | 20.18M | 18.62M | 16.04M |
Gross Profit | 5.43M | 3.31M | 3.85M | 4.23M | 2.57M | 3.67M | 3.58M | 3.16M | 3.26M | 4.17M | 3.61M | 2.8M | 1.69M | n/a | -3.28M | -3.31M | -3.31M | -3.28M |
Operating Income | -35.33M | -40.4M | -42.44M | -41.48M | -42.06M | -39.77M | -40.89M | -41.64M | -39.93M | -39.52M | -36.95M | -32.67M | -30.19M | -27.16M | -23.82M | -24.23M | -23.71M | -22.1M |
Interest Income | 591K | 704K | 697K | 635K | 388K | 213K | 179K | 125K | 87K | 46K | 29K | 16K | 7K | 4K | 5K | 4K | 8K | 28K |
Pretax Income | -25.71M | -426K | -18.92M | -41.36M | -67.04M | -79.58M | -69.05M | -59.51M | -36.97M | -42.63M | -36.92M | -32.65M | -29.45M | -26.43M | -23.16M | -23.73M | -24.08M | -22.6M |
Net Income | -25.71M | -426K | -18.92M | -41.36M | -67.04M | -79.58M | -69.05M | -59.5M | -36.94M | -42.61M | -36.89M | -32.64M | -29.45M | -26.43M | -23.16M | -23.73M | -24.08M | -22.6M |
Selling & General & Admin | 12.44M | 13.26M | 13.18M | 13.04M | 13.38M | 12.29M | 11.65M | 10.28M | 8.26M | 7.99M | 7.44M | 7.85M | 8.06M | 8.11M | 8.28M | 8.04M | 8.11M | 7.95M |
Research & Development | 29.76M | 31.84M | 34.43M | 33.9M | 32.4M | 32.18M | 33.77M | 35.41M | 35.83M | 36.59M | 35.02M | 30.26M | 27.49M | 23.69M | 20.02M | 20.18M | 18.62M | 16.04M |
Other Expenses | -1.45M | -1.39M | -1.33M | -1.25M | -1.15M | -1.81M | -2.29M | -3.05M | -4.17M | -5.07M | -5.51M | -5.45M | -5.36M | -4.64M | -4.47M | -3.99M | -3.03M | -1.89M |
Operating Expenses | 40.75M | 43.7M | 46.28M | 45.7M | 44.63M | 42.66M | 43.13M | 42.64M | 39.93M | 39.52M | 30.16M | 25.87M | 23.39M | 20.37M | 20.54M | 16.47M | 12.17M | 7.95M |
Interest Expense | 13.61M | 12.52M | 10.74M | 8.91M | 7.16M | 4.45M | 2.63M | 1.18M | n/a | n/a | n/a | n/a | 2K | 2K | 64K | 241K | 389K | 531K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 42.2M | 45.1M | 47.61M | 46.94M | 45.78M | 43.49M | 43.64M | 42.87M | 39.93M | 39.52M | 38.18M | 33.9M | 31.42M | 28.4M | 23.82M | 24.23M | 23.71M | 22.13M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -14K | -23K | -28K | -29K | -14K | -3K | 4K | 5K | 10K | 12K | 32K |
Shares Outstanding (Basic) | 36.19M | 36.19M | 36.18M | 36.18M | 36.16M | 36.13M | 36.1M | 36.09M | 36.07M | 36.05M | 36.05M | 36.04M | 35.44M | 29M | 24.1M | 24.82M | 24.76M | 20.46M |
Shares Outstanding (Diluted) | 36.19M | 36.19M | 59.08M | 36.18M | 58.25M | 36.13M | 36.1M | 36.09M | 36.07M | 36.05M | 36.05M | 36.04M | 36M | 29M | 24.1M | 24.82M | 24.76M | 20.46M |
EPS (Basic) | -0.71 | -0.01 | -0.52 | -1.14 | -1.85 | -2.2 | -1.91 | -1.65 | -1.03 | -1.19 | -1.09 | -1.05 | -1.03 | -1.02 | -0.99 | -1.14 | -1.23 | -1.24 |
EPS (Diluted) | -0.74 | -0.54 | -1.05 | -1.64 | -2.35 | -2.2 | -1.91 | -1.65 | -1.03 | -1.19 | -1.09 | -1.05 | -1.03 | -1.02 | -0.99 | -1.14 | -1.23 | -1.24 |
EBITDA | -10.66M | 13.48M | -6.85M | -31.21M | -58.73M | -74.07M | -65.45M | -57.41M | -36.04M | -41.74M | -36.03M | -31.73M | -28.45M | -25.32M | -21.92M | -22.32M | -22.58M | -20.97M |
EBIT | -12.09M | 12.1M | -8.18M | -32.45M | -59.88M | -75.13M | -66.42M | -58.34M | -36.97M | -42.64M | -36.92M | -32.66M | -29.46M | -26.43M | -23.09M | -23.49M | -23.69M | -22.07M |
Depreciation & Amortization | 1.44M | 1.39M | 1.32M | 1.24M | 1.15M | 1.03M | 944K | 896K | 901K | 901K | 898K | 930K | 1M | 1.1M | 1.16M | 1.15M | 1.12M | 1.1M |